Clinical Trial Update: microRNAs Tool for Stratifying Stage II Colon Cancer

View source ↗

Summary

Clinical trial evaluating microRNAs as a tool to stratify patients with stage II colon cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Colonic Neoplasms, Effects of Chemotherapy | Status: UNKNOWN